EarningsQ2 2026 Earnings Report
DE:NBF Q2 2026 EPS Results
Actual EPS€0.06
Consensus EPS€0.06
Beat/MissMissed by -<€0.01
One Year Ago EPS€0.07
DE:NBF Q2 2026 Revenue Results
Actual Revenue€219.36M
Expected Revenue€219.27M
Beat/MissBeat by +€89.39K
YoY Revenue Growth+2.46%
Earnings Announcement Details
QuarterQ2 2026
Date07/17/2026
TimeBefore Open
Conference CallFriday, July 17, 2026
DE:NBF Upcoming Earnings
Nolato AB's next earnings date is estimated for October 29, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:NBF Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a generally positive operational picture with continued top-line growth (currency-adjusted), strong cash generation, a notable 19% materials surge, and progress on strategic capacity expansions (Hungary, Malaysia, Poland). These positives are tempered by margin pressure from higher raw material costs (~SEK 20m), start-up costs in Medical (~SEK 10m), a SEK 6m severance item and somewhat elevated group costs related to M&A activity. Segment-specific soft patches (hygiene and automotive) and a modest dip in ROCE were noted but appear manageable given the strong balance sheet and stated ability to pass on costs and ramp volumes. Overall, the highlights outweigh the lowlights, driven by growth, cash flow and a strong balance sheet enabling future M&A and capacity build-out.Company Guidance
Revenue Growth and Total Sales
Net sales of SEK 2,454 million (close to SEK 2.5 billion) in Q2; reported 4% currency-adjusted growth for the quarter with group-level organic growth commentary from management.
Strong Cash Generation and Lower Net Investments
Strong operating cash flow noted (SEK 287 million cited for the quarter) and cash flow after investments of SEK 154 million (up from SEK 128 million). Net investments decreased to SEK 133 million from SEK 188 million; full-year CapEx guidance reduced to SEK 600–650 million.
Materials Business Surge
Materials within Engineered Solutions delivered strong performance with ~19% organic growth in the quarter, contributing positively to the product mix and supporting margin resilience in the segment.
Medical Solutions Continued Growth and Capacity Expansion
Medical Solutions sales close to SEK 1.4 billion with ~4% currency-adjusted growth. EBITA margin for Medical was 11.7%. Key expansions progressed: Hungary site started commercial volumes at end of Q2 and will ramp toward full volumes over coming years; additional capacity expansions in Malaysia and Poland underway.
Engineered Solutions Sustained Areas of Strength
Engineered Solutions sales close to SEK 1.1 billion with ~3% currency-adjusted growth. Continued growth in consumer electronics (smart home) and positive traction in data-center related material technologies.
Strong Balance Sheet and M&A Capacity
Net financial liabilities (excluding pension and lease liabilities) of SEK 1,055 million and net debt/EBITA of ~0.7x. Management states a strong financial position enabling an intensified acquisition (M&A) agenda.
DE:NBF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed